COMMUNIQUÉS West-GlobeNewswire

Pernix Therapeutics Announces Participation in Lead Bid for Acquisition of Worldwide Rights to Contrave® for Weight Loss

23/04/2018 - 17:30

MORRISTOWN, N.J, April 23, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ), a specialty pharmaceutical company, today announced that it has agreed to participate in an investor group ( [...]

New Jersey Trying to Ramrod Mandatory Vaccination over Parental Concerns, States the Association of American Physicians and Surgeons (AAPS)

23/04/2018 - 16:10

TUCSON, Ariz., April 23, 2018 (GLOBE NEWSWIRE) -- In a shocking display of arrogance as detailed by Steve Frank , columnist for the Asbury Park Press , a physician-legislator railroaded a bill sharply limiting religious [...]

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

23/04/2018 - 16:01

New Indication Expands DCB Treatment for Patients with SFA Lesions Up to 360mm DUBLIN - April 23, 2018 - Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval [...]

Nexstim Plc appoints Sisu Partners as new Certified Adviser

23/04/2018 - 16:01

Company announcement, Helsinki, 23 April 2018 at 5:00 PM Nexstim Plc appoints Sisu Partners as new Certified Adviser Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted neuromodulation company [...]

Tabula Rasa Healthcare to Announce First Quarter 2018 Operating Results and Host Conference Call on Tuesday, May 8, 2018

23/04/2018 - 16:00

MOORESTOWN, N.J., April 23, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC ), a healthcare technology company that develops and employs medication risk mitigation software solutions and tools to [...]

Novo Nordisk A/S: Share repurchase programme

23/04/2018 - 15:54

Bagsværd, Denmark, 23 April 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]

Immuron’s Travelan® Sales Continue to Soar in Third Quarter of FY2018 in Australian & US Markets

23/04/2018 - 15:30

Key Highlights: US Travelan® sales continue an upward trend with a 95% increase in the Third Quarter of 2018 compared to the same period last year. YTD US sales (End March 2018) climbed to $AUD501K, representing a [...]

UPDATE -- Intellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell Therapy 21st Annual Meeting

23/04/2018 - 15:29

CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ: NTLA ), a leading genome editing company focused on the development of curative therapeutics using CRISPR/Cas9 technology, [...]

Sienna Senior Living Announces Redemption of Extendible Convertible Unsecured Subordinated Debentures

23/04/2018 - 15:00

MARKHAM, Ontario, April 23, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) announced today that it intends to exercise its right to redeem on May 23, 2018 (the “ [...]

OrthoPediatrics Corp. to Report First Quarter 2018 Financial Results on May 14, 2018

23/04/2018 - 15:00

Conference Call to Discuss Results on May 15, 2018 at 8:00 a.m. ET WARSAW, Ind., April 23, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS ), an orthopedic company focused exclusively on [...]

AXIM Biotech Secures Additional Funding to Advance Cannabidnoid-Based Clinical Development Program for Multiple Indications

23/04/2018 - 15:00

NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (AXIM ) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company has secured additional funding [...]

Ceapro Inc. Provides Corporate Update

23/04/2018 - 15:00

- Company well poised to transition to its next phase of growth for expansion into the profitable nutraceutical sector over the next 12 months - - Data expected from the bioavailability study of CoQ10-beta glucan and [...]

Progyny Launches Two How-To Guides to Support Employers and their Employees as they Navigate Infertility in the Workplace

23/04/2018 - 15:00

NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- In support of National Infertility Awareness Week (NIAW), Progyny, the leading fertility benefits management company, announced today the launch of two “How-To” guides geared [...]

Vous avez le feu vert pour sauver des vies : Semaine nationale de sensibilisation au don d’organes et de tissus (22-28 avril)

23/04/2018 - 15:00

À l’occasion de cette semaine de sensibilisation, nous souhaitons rappeler aux Canadiennes et aux Canadiens qu’ils doivent faire part à leurs proches de leur décision et de leurs volontés concernant le don d’organes. [...]

You have the green light to save a life: April 22-28 is National Organ and Tissue Donation Awareness Week

23/04/2018 - 15:00

This week we remind Canadians to talk with their friends, family and loved ones to ensure their organ donation wishes and decisions are understood. OTTAWA, April 23, 2018 (GLOBE NEWSWIRE) -- Green is the official colour [...]

Abba Medix Receives its License to Produce Cannabis Oil

23/04/2018 - 14:57

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 23, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to [...]

Wildflower Completes Acquisition of Retail and Cultivation Licenses in LA

23/04/2018 - 14:50

VANCOUVER, British Columbia, April 23, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (FWB:RSP) (“ Wildflower ” or the " Company ") has completed the acquisition of multiple California marijuana licenses [...]

AzurRx BioPharma and Mayoly-Spindler Announce Additional Positive Interim Data for MS1819-SD Phase II in Exocrine Pancreatic Insufficiency (EPI)

23/04/2018 - 14:45

BROOKLYN, N.Y., April 23, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), today provided an update on the first nine treated patients in its ongoing Phase IIa trial of MS1819- [...]

Sarepta Therapeutics to Announce First Quarter 2018 Financial Results and Recent Corporate Developments on May 3, 2018

23/04/2018 - 14:30

CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]